Friedenthal Financial’s Elevance Health ELV Stock Holding History

Friedenthal Financial’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,916	Closed	-$1.13M	–	362
2026 Q2	$1.13M	Buy	+2,916	New	+$1.08M	0.52%	49

Other funds holding ELV

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Friedenthal Financial's ELV Position: Q3 2026 in Review

Friedenthal Financial sold out of Elevance Health (ELV) in Q3 2026, closing a stake of 2,916 shares — an estimated $1.13M sold.

Friedenthal Financial first reported a position in ELV in Q2 2026 and held it in 1 quarter. The position peaked at $1.13M in Q2 2026. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Friedenthal Financial reported no remaining Elevance Health position as of Q3 2026 after selling out during the quarter.
Friedenthal Financial sold 2,916 Elevance Health shares in Q3 2026, an estimated $1.13M.
Friedenthal Financial first reported a position in Elevance Health in Q2 2026 and held it in 1 quarter.
Friedenthal Financial's Elevance Health position peaked at $1.13M in Q2 2026.
1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Friedenthal Financial's 13F filing for Q3 2026, filed 27 Oct 2026.